PMID- 19164327 OWN - NLM STAT- MEDLINE DCOM- 20090825 LR - 20090521 IS - 1460-2385 (Electronic) IS - 0931-0509 (Linking) VI - 24 IP - 6 DP - 2009 Jun TI - Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. PG - 1952-6 LID - 10.1093/ndt/gfn748 [doi] AB - BACKGROUND: End stage renal disease increases the risk of reactivating latent tuberculosis (LTBI). Interferon-gamma release assays (IGRA) are an alternative to the tuberculin skin test (TST) for detecting LTBI. METHODS: Sixty-two hemodialysis patients (46 male, 16 female, aged 65 +/- 15 years) from 3 hemodialysis facilities in the Geneva area were submitted to a TST, 2 IGRA (T-SPOT.TB and QuantiFERON Gold in tube: QFT), a chest radiography, and a questionnaire to record social status, country of birth, history of prior TST, tuberculosis (TB), BCG (Bacillus of Calmette-Guerin vaccine), and any cause of immuno-suppression. LTBI was defined as prior "at risk" contact with a case of contagious TB and/or a chest X-ray suggestive of prior TB infection. RESULTS: Positivity rate was 19% for TST, 21% for QFT and 29% for T-SPOT-TB; 8% of QFT and 11% of T-SPOT-TB were indeterminate. Agreement between IGRA was fair (kappa = 0.60). After adjusting for age and BCG, OR (Odds Ratio) of having a positive QFT was 4.6-fold (p = 0.029) higher in patients with LTBI vs. those without LTBI. In contrast, no association was found between LTBI and having a positive T-SPOT.TB or a positive TST. As expected, there was a strong association between prior BCG vaccination and having a positive TST (OR 5.3, p = 0.017). QFT was the only test with a significant OR of having LTBI (adjusted OR: 4.4; 95%CI: 1.1 - 17.6; p = 0.034). Among 5 patients with definite prior TB, TST and T-SPOT.TB were positive in 1 and QFT, in 2. CONCLUSIONS: In this population, QFT was superior to TST for detecting LTBI, but both IGRAs and TST have important limitations, and are unreliable for screening for LTBI. FAU - Triverio, Pierre-Alain AU - Triverio PA AD - Division of Nephrology, Geneva University Hospital, 1211 Geneva 14, Switzerland. FAU - Bridevaux, Pierre-Olivier AU - Bridevaux PO FAU - Roux-Lombard, Pascale AU - Roux-Lombard P FAU - Niksic, Laurent AU - Niksic L FAU - Rochat, Thierry AU - Rochat T FAU - Martin, Pierre-Yves AU - Martin PY FAU - Saudan, Patrick AU - Saudan P FAU - Janssens, Jean-Paul AU - Janssens JP LA - eng PT - Clinical Trial PT - Comparative Study PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20090122 PL - England TA - Nephrol Dial Transplant JT - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association JID - 8706402 RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Aged MH - Aged, 80 and over MH - Female MH - Humans MH - Interferon-gamma/*blood MH - Kidney Failure, Chronic/*complications/immunology/*therapy MH - Male MH - Middle Aged MH - Predictive Value of Tests MH - *Renal Dialysis MH - *Tuberculin Test MH - Tuberculosis, Pulmonary/*diagnosis/*etiology/immunology EDAT- 2009/01/24 09:00 MHDA- 2009/08/26 09:00 CRDT- 2009/01/24 09:00 PHST- 2009/01/24 09:00 [entrez] PHST- 2009/01/24 09:00 [pubmed] PHST- 2009/08/26 09:00 [medline] AID - gfn748 [pii] AID - 10.1093/ndt/gfn748 [doi] PST - ppublish SO - Nephrol Dial Transplant. 2009 Jun;24(6):1952-6. doi: 10.1093/ndt/gfn748. Epub 2009 Jan 22.